BTA management are the ones who brought us the LANI deal, RSV and HCV deals of late. Are they really that bad? If anything I would point the finger at GSK for not marketing effectively.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint